• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发灶不明癌:关于其临床实体识别及标准治疗管理的病例报告

Cancer of Unknown Primary: A Case Report on the Recognition of Its Clinical Entity and Standard of Care Management.

作者信息

Lazzaro Alexander, Srinivasan Maya, Assi Hussein

机构信息

Medicine, Boston Medical Center, Boston University Chobanian and Avedisian School of Medicine, Boston, USA.

Hematology and Oncology, Boston Medical Center, Boston University Chobanian and Avedisian School of Medicine, Boston, USA.

出版信息

Cureus. 2025 Jun 20;17(6):e86451. doi: 10.7759/cureus.86451. eCollection 2025 Jun.

DOI:10.7759/cureus.86451
PMID:40548152
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12180934/
Abstract

Cancer of unknown primary (CUP) is a distinct and well-established clinical entity that encompasses a heterogeneous group of histologically proven cancers that present unique diagnostic and therapeutic challenges. This case describes a male patient in his late 60s who presented with nonspecific gastrointestinal complaints. A comprehensive workup, including clinical evaluation and various biochemical, imaging, and invasive histopathologic tests, led to the diagnosis of CUP following consultation with medical oncology specialists. A decision was made to forgo further invasive molecular tissue sampling in search of a primary malignant process in favor of initiating systemic chemotherapy. The patient possessed an unfavorable set of prognostic signs. Rapid clinical deterioration occurred the day after treatment initiation. A goals of care conversation led to a transition towards comfort measures only care, and the patient ultimately passed away. This case highlights the importance of non-oncologically trained providers recognizing CUP as its own entity to facilitate standard of care management. Future research is needed to establish benefits in clinical trials looking at molecular tumor profiling and site-specific therapies for this rare malignancy.

摘要

原发灶不明的癌症(CUP)是一种独特且已被充分认知的临床实体,它包含一组组织学确诊的癌症,这些癌症具有异质性,在诊断和治疗上面临独特挑战。本病例描述了一名60多岁的男性患者,他出现了非特异性胃肠道症状。经过全面检查,包括临床评估以及各种生化、影像学和侵入性组织病理学检查,并与肿瘤内科专家会诊后,确诊为CUP。决定放弃进一步进行侵入性分子组织采样以寻找原发性恶性病变,转而开始全身化疗。该患者具有一组不良的预后体征。治疗开始后第二天,患者临床状况迅速恶化。关于护理目标的讨论导致护理模式转变为仅采取舒适措施,患者最终去世。本病例强调了未接受肿瘤学培训的医疗人员将CUP视为独立实体以促进规范护理管理的重要性。未来需要开展研究,以确定在针对这种罕见恶性肿瘤的分子肿瘤分析和特定部位治疗的临床试验中的获益情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70bd/12180934/4254179bce00/cureus-0017-00000086451-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70bd/12180934/97ffc950fd14/cureus-0017-00000086451-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70bd/12180934/4254179bce00/cureus-0017-00000086451-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70bd/12180934/97ffc950fd14/cureus-0017-00000086451-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70bd/12180934/4254179bce00/cureus-0017-00000086451-i02.jpg

相似文献

1
Cancer of Unknown Primary: A Case Report on the Recognition of Its Clinical Entity and Standard of Care Management.原发灶不明癌:关于其临床实体识别及标准治疗管理的病例报告
Cureus. 2025 Jun 20;17(6):e86451. doi: 10.7759/cureus.86451. eCollection 2025 Jun.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
3
NIH Consensus Statement on Management of Hepatitis C: 2002.美国国立卫生研究院关于丙型肝炎管理的共识声明:2002年。
NIH Consens State Sci Statements. 2002;19(3):1-46.
4
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
7
Early warning systems and rapid response systems for the prevention of patient deterioration on acute adult hospital wards.急性成人病房患者恶化的预防用早期预警系统和快速反应系统。
Cochrane Database Syst Rev. 2021 Nov 22;11(11):CD005529. doi: 10.1002/14651858.CD005529.pub3.
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
9
The measurement and monitoring of surgical adverse events.手术不良事件的测量与监测
Health Technol Assess. 2001;5(22):1-194. doi: 10.3310/hta5220.
10
Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours: systematic review and economic evaluation.伊马替尼治疗不可切除和/或转移性胃肠道间质瘤患者:系统评价与经济学评估
Health Technol Assess. 2005 Jul;9(25):1-142. doi: 10.3310/hta9250.

本文引用的文献

1
Risk factors for cancer of unknown primary: a literature review.不明原发灶癌症的危险因素:文献综述。
BMC Cancer. 2023 Apr 5;23(1):314. doi: 10.1186/s12885-023-10794-6.
2
Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.原发灶不明癌:ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2023 Mar;34(3):228-246. doi: 10.1016/j.annonc.2022.11.013. Epub 2022 Dec 20.
3
Pancreatic Cancer: A Review.胰腺癌:综述。
JAMA. 2021 Sep 7;326(9):851-862. doi: 10.1001/jama.2021.13027.
4
Cholangiocarcinoma.胆管癌。
Nat Rev Dis Primers. 2021 Sep 9;7(1):65. doi: 10.1038/s41572-021-00300-2.
5
The currently declining incidence of cancer of unknown primary.目前不明原发灶癌症的发病率正在下降。
Cancer Epidemiol. 2019 Aug;61:139-141. doi: 10.1016/j.canep.2019.06.006. Epub 2019 Jun 26.
6
Patterns of care and survival after a cancer of unknown primary (CUP) diagnosis: A population-based nested cohort study in Australian Government Department of Veterans' Affairs clients.不明原发癌(CUP)诊断后的治疗模式与生存情况:一项基于澳大利亚退伍军人事务部客户群体的巢式队列研究
Cancer Epidemiol. 2015 Aug;39(4):578-84. doi: 10.1016/j.canep.2015.02.007. Epub 2015 Jun 20.
7
Cancers of unknown primary origin (CUP) are characterized by chromosomal instability (CIN) compared to metastasis of know origin.与已知原发灶的转移瘤相比,原发灶不明的癌症(CUP)具有染色体不稳定(CIN)的特征。
BMC Cancer. 2015 Mar 19;15:151. doi: 10.1186/s12885-015-1128-x.
8
Molecular profiling diagnosis in unknown primary cancer: accuracy and ability to complement standard pathology.不明原发肿瘤的分子谱诊断:准确性和对标准病理学的补充能力。
J Natl Cancer Inst. 2013 Jun 5;105(11):782-90. doi: 10.1093/jnci/djt099. Epub 2013 May 2.
9
NCCN Clinical Practice Guidelines Occult primary.NCCN 临床实践指南 隐匿性原发灶。
J Natl Compr Canc Netw. 2011 Dec;9(12):1358-95. doi: 10.6004/jnccn.2011.0117.
10
Survival in cancer of unknown primary site: population-based analysis by site and histology.不明原发灶癌的生存情况:基于部位和组织学的人群分析。
Ann Oncol. 2012 Jul;23(7):1854-63. doi: 10.1093/annonc/mdr536. Epub 2011 Nov 24.